Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of Combined Thoracic and Diaphragmatic Breathing on Cognitive and Psycho-Physiological Functions

27 de mayo de 2026 actualizado por: National Taiwan University Clinical Trial Center

The Effects of Combined Thoracic Expansion Exercises and Slow Diaphragmatic Breathing on Cognitive Function, Brain Activation, Psychological Status, and Head-Shoulder Posture in Healthy Adults

This study aims to investigate the effects of a combined thoracic expansion exercise (TEE) and slow diaphragmatic breathing (SDB) program on cognitive function, brain activation, psychological status, and head-shoulder posture in healthy young adults.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Yun Syuan Lin
  • Número de teléfono: +886 986161796
  • Correo electrónico: b11408046@ntu.edu.tw

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Descripción

Inclusion Criteria:

  1. age between 18 to 30 years with at least a high school education to ensure baseline cognitive task comprehension
  2. the ability to adhere to verbal instructions
  3. no regular participation in formal breathing exercise or mindfulness training within the past six months.

Exclusion Criteria:

  1. a history of musculoskeletal, cardiovascular, or cerebrovascular diseases which may interfere this study
  2. history of respiratory disease or recent respiratory infection
  3. diabetes mellitus with neuropathy, peripheral neuropathy, or other neurological disorders
  4. major surgery within the past six months
  5. Current or past major psychiatric disorders or cognitive impairment
  6. use of medications significantly affecting cerebral hemodynamics or autonomic function (e.g., beta-blockers, vasodilators) within the past 2 weeks
  7. use of psychotropic medications or substances known to alter cerebral blood flow, neural activation, or autonomic regulation (e.g., antidepressants, antipsychotics, anxiolytics, stimulants, or sedative-hypnotics).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: rhythmic breathing exercise group
The rhythmic breathing exercise group will perform 10 minutes of thoracic expansion exercises followed by 15 minutes of progressive diaphragmatic breathing (4-s inhalation/6-s exhalation) to facilitate parasympathetic dominance.
4-week supervised training program, consisting of three 30-minute sessions per week. Thoracic expansion exercises consists of chest wall stretching and mobility drills. Followed by 15 minutes of progressive slow diaphragmatic breathing (4-s inhalation/6-s exhalation).
Comparador falso: natural breathing exercise group
The natural breathing exercise group performed sham thoracic expansion exercises and sham slow diaphragmatic breathing
During sham TEE, participants perform comfortable thoracic movements without foam rollers or specific breathing coordination. During sham SDB, they maintain a spontaneous, natural respiratory rhythm in relaxed postures. Crucially, the sham protocol lacks the rhythmic pacing (4:6s), diaphragmatic depth cues, and resistance-based progression required to trigger the neuro-cognitive "respiratory-brain" axis.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change from baseline in Working Memory
Periodo de tiempo: Baseline, Week 5 (post-intervention)
Assessed by the 2-back task. The outcome is calculated as the change in accuracy (percentage of correct responses) and reaction time. Accuracy range from 0% to 100%. Higher accuracy and lower reaction time indicate better working memory capacity.
Baseline, Week 5 (post-intervention)
Change from baseline in Inhibitory Control
Periodo de tiempo: Baseline, Week 5 (post-intervention)
Measured by the Stop-signal task (SST). The outcome is the change in Stop-Signal Reaction Time (SSRT) in milliseconds. SSRT values typically range from 100 to 500 milliseconds, with lower scores (faster reaction time) indicating better inhibitory control.
Baseline, Week 5 (post-intervention)
Change from baseline in Mental Set Shifting
Periodo de tiempo: Baseline, Week 5 (post-intervention)
Assessed using the Wisconsin Card Sorting Test (WCST). The outcome include the number of categories achieved, perseverative errors and set-loss errors. Higher number of categories achieved, lower perseverative errors and set-loss errors indicate better cognitive flexibility and set-shifting ability.
Baseline, Week 5 (post-intervention)
Change from baseline in Short-Term Memory
Periodo de tiempo: Baseline, Week 5 (post-intervention)
Assessed using the Corsi Block-Tapping Task. The outcome is Corsi span score. The Corsi span is defined as the longest sequence accurately reproduced by participants. Scores range from 0 to 9 blocks, with higher scores indicating better short-term memory capacity.
Baseline, Week 5 (post-intervention)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Heart Rate Variability (HRV)
Periodo de tiempo: Baseline and Week 5 (post-intervention)
HRV will be assessed as a non-invasive marker of autonomic nervous system (ANS) flexibility and neurovisceral integration, reflecting the dynamic regulation of the prefrontal-vagal pathway. Higher HRV serves as a physiological indicator of superior executive function and emotional regulation, whereas lower values are linked to autonomic dysregulation and cognitive fatigue. Data will be captured using a validated Polar H10 chest strap and the Elite HRV application for precise R-R interval detection. Outcome measurement include time-domain indices (SDNN, RMSSD), frequency-domain measures (HF, LF, and LF/HF ratio), and non-linear metrics (SD1, SD2). Increased RMSSD and HF power will be interpreted as enhanced parasympathetic modulation, providing the physiological foundation for improved attentional control and neural efficiency.
Baseline and Week 5 (post-intervention)
Change in Posture Alignment
Periodo de tiempo: Baseline and Week 5 (post-intervention)
  1. Craniovertebral angle (CVA) Measured from a lateral-view in a relaxed standing position. Participants look forward and maintain a comfortable stance during image acquisition. The CVA is the angle between a line connecting the tragus of the ear to the C7 spinous process and a horizontal line passing through C7. A Smaller angle indicates more severe forward head posture.
  2. Acromion-to-table distance (ATD) While supine, the vertical distance between the posterior aspect of the acromion and the table surface is measured. A larger distance indicates increased rounded shoulder posture or thoracic kyphosis.
Baseline and Week 5 (post-intervention)
Change in Psychological status
Periodo de tiempo: Baseline and Week 5 (post-intervention)
The Traditional Chinese version of Depression Anxiety Stress Scales-21 (DASS-21) will be used to assess negative emotional states including depression, anxiety, and stress. DASS-21 contains 21 items, with 7 items assigned to each subscale. Participants rate their symptoms over the past week on a 4-point scale ranging from 0 ("did not apply to me at all") to 3 ("applied to me very much or most of the time") in each question. Subscale scores are obtained by summing the 7 items and multiply by two within each domain, with higher scores indicating greater severity of emotional distress.
Baseline and Week 5 (post-intervention)
Change in Brain Activation
Periodo de tiempo: Baseline and Week 5 (post-intervention)
Brain activation in the prefrontal cortex, primary motor cortex, supplementary motor area, and premotor cortex during tasks is assessed using functional near-infrared spectroscopy (fNIRS). The specific metric reported is the change in the concentration of oxygenated hemoglobin (HbO). Higher HbO values indicate increased regional cerebral blood flow and higher brain activation.
Baseline and Week 5 (post-intervention)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Yan Ci Liu, School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

25 de mayo de 2026

Finalización primaria (Estimado)

1 de febrero de 2027

Finalización del estudio (Estimado)

1 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

11 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

27 de mayo de 2026

Publicado por primera vez (Actual)

2 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

27 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 202603092RIN

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir